-
1
-
-
0021892937
-
Effect of estrogens and antiestrogens on growth-regulatory enzymes in human breast cancer cells in tissue culture
-
Aitken S.C., Lippman M.E. Effect of estrogens and antiestrogens on growth-regulatory enzymes in human breast cancer cells in tissue culture. Cancer Res. 1985, 45:1611-1620.
-
(1985)
Cancer Res.
, vol.45
, pp. 1611-1620
-
-
Aitken, S.C.1
Lippman, M.E.2
-
2
-
-
0000151275
-
Pharmacology of inhibitors of estrogen biosynthesis
-
Springer-Verlag, Berlin, Heidelberg, G.V. Born, M. Oettel, E. Schillinger (Eds.) Handbook of Experimental Pharmacology
-
Bhatnagar A.S., Miller W.R. Pharmacology of inhibitors of estrogen biosynthesis. Estrogens Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogens 1999, vol. 135(2):223-230. Springer-Verlag, Berlin, Heidelberg. G.V. Born, M. Oettel, E. Schillinger (Eds.).
-
(1999)
Estrogens Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogens
, vol.135
, Issue.2
, pp. 223-230
-
-
Bhatnagar, A.S.1
Miller, W.R.2
-
3
-
-
69549131213
-
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
-
Creighton C.J., Li X., Landis M., Dixon J.M., Neumeister V.M., Sjolund A., Rimm D.L., Wong H., Rodriguez A., Herschkowitz J.I., Fan C., Zhang X., He X., Pavlick A., Gutierrez M.C., Renshaw L., Larionov A.A., Faratian D., Hilsenbeck S.G., Perou C.M., Lewis M.T., Rosen J.M., Chang J.C. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13820-13825.
-
(2009)
Proc. Natl. Acad. Sci. U.S.A.
, vol.106
, pp. 13820-13825
-
-
Creighton, C.J.1
Li, X.2
Landis, M.3
Dixon, J.M.4
Neumeister, V.M.5
Sjolund, A.6
Rimm, D.L.7
Wong, H.8
Rodriguez, A.9
Herschkowitz, J.I.10
Fan, C.11
Zhang, X.12
He, X.13
Pavlick, A.14
Gutierrez, M.C.15
Renshaw, L.16
Larionov, A.A.17
Faratian, D.18
Hilsenbeck, S.G.19
Perou, C.M.20
Lewis, M.T.21
Rosen, J.M.22
Chang, J.C.23
more..
-
4
-
-
0035752337
-
Genes that co-cluster with estrogen receptor alpha in microarray analysis of breast biopsies
-
Dressman M.A., Walz T.M., Lavedan C., Barnes L., Buchholtz S., Kwon I., Ellis M.J., Polymeropoulos M.H. Genes that co-cluster with estrogen receptor alpha in microarray analysis of breast biopsies. Pharmacogenomics J. 2001, 1:135-141.
-
(2001)
Pharmacogenomics J.
, vol.1
, pp. 135-141
-
-
Dressman, M.A.1
Walz, T.M.2
Lavedan, C.3
Barnes, L.4
Buchholtz, S.5
Kwon, I.6
Ellis, M.J.7
Polymeropoulos, M.H.8
-
5
-
-
0035884620
-
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial
-
Ellis M.J., Coop A., Singh B., Mauriac L., Llombert-Cussac A., Janicke F., Miller W.R., Evans D.B., Dugan M., Brady C., Quebe-Fehling E., Borgs M. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. J. Clin. Oncol. 2001, 19:3808-3816.
-
(2001)
J. Clin. Oncol.
, vol.19
, pp. 3808-3816
-
-
Ellis, M.J.1
Coop, A.2
Singh, B.3
Mauriac, L.4
Llombert-Cussac, A.5
Janicke, F.6
Miller, W.R.7
Evans, D.B.8
Dugan, M.9
Brady, C.10
Quebe-Fehling, E.11
Borgs, M.12
-
6
-
-
43249121177
-
Stromal gene expression predicts clinical outcome in breast cancer
-
Finak G., Bertos N., Pepin F., Sadekova S., Souleimanova M., Zhao H., Chen H., Omeroglu G., Meterissian S., Omeroglu A., Hallett M., Park M. Stromal gene expression predicts clinical outcome in breast cancer. Nat. Med. 2008, 14:518-527.
-
(2008)
Nat. Med.
, vol.14
, pp. 518-527
-
-
Finak, G.1
Bertos, N.2
Pepin, F.3
Sadekova, S.4
Souleimanova, M.5
Zhao, H.6
Chen, H.7
Omeroglu, G.8
Meterissian, S.9
Omeroglu, A.10
Hallett, M.11
Park, M.12
-
7
-
-
0030012189
-
Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells
-
Foster J.S., Wimalasena J. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Mol. Endocrinol. 1996, 10:488-498.
-
(1996)
Mol. Endocrinol.
, vol.10
, pp. 488-498
-
-
Foster, J.S.1
Wimalasena, J.2
-
8
-
-
0141785350
-
Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype
-
Frasor J., Danes J.M., Komm B., Chang K.C., Lyttle C.R., Katzenellenbogen B.S. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 2003, 144:4562-4574.
-
(2003)
Endocrinology
, vol.144
, pp. 4562-4574
-
-
Frasor, J.1
Danes, J.M.2
Komm, B.3
Chang, K.C.4
Lyttle, C.R.5
Katzenellenbogen, B.S.6
-
9
-
-
0033677086
-
PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer
-
Ghosh M.G., Thompson D.A., Weigel R.J. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res. 2000, 60:6367-6375.
-
(2000)
Cancer Res.
, vol.60
, pp. 6367-6375
-
-
Ghosh, M.G.1
Thompson, D.A.2
Weigel, R.J.3
-
10
-
-
56549102420
-
Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance
-
Harvell D.M., Spoelstra N.S., Singh M., McManaman J.L., Finlayson C., Phang T., Trapp S., Hunter L., Dye W.W., Borges V.F., Elias A., Horwitz K.B., Richer J.K. Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance. Breast Cancer Res. Treat. 2008, 112:475-488.
-
(2008)
Breast Cancer Res. Treat.
, vol.112
, pp. 475-488
-
-
Harvell, D.M.1
Spoelstra, N.S.2
Singh, M.3
McManaman, J.L.4
Finlayson, C.5
Phang, T.6
Trapp, S.7
Hunter, L.8
Dye, W.W.9
Borges, V.F.10
Elias, A.11
Horwitz, K.B.12
Richer, J.K.13
-
11
-
-
17144420079
-
Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach
-
Itoh T., Karlsberg K., Kijima I., Yuan Y.C., Smith D., Ye J., Chen S. Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach. Mol. Cancer Res. 2005, 3:203-218.
-
(2005)
Mol. Cancer Res.
, vol.3
, pp. 203-218
-
-
Itoh, T.1
Karlsberg, K.2
Kijima, I.3
Yuan, Y.C.4
Smith, D.5
Ye, J.6
Chen, S.7
-
12
-
-
0001730310
-
Oestrogen uptake and metabolism in vivo
-
B
-
James V.H.T., Reed M.J., Adams E.F., Ghilchik M.W., Lai L.C., Coldham N.G., Newton C.J., Purohit A., Owen A.M., Singh A., Islam S. Oestrogen uptake and metabolism in vivo. Proc. R. Soc. Edinburgh 1989, 95B:185-193.
-
(1989)
Proc. R. Soc. Edinburgh
, vol.95
, pp. 185-193
-
-
James, V.H.T.1
Reed, M.J.2
Adams, E.F.3
Ghilchik, M.W.4
Lai, L.C.5
Coldham, N.G.6
Newton, C.J.7
Purohit, A.8
Owen, A.M.9
Singh, A.10
Islam, S.11
-
13
-
-
79956139441
-
Tamoxifen for the treatment of breast cancer
-
Haman Press, Totowa N.J., USA, V.C. Jordan, B.R.A. Furr (Eds.)
-
Jordan V.C. Tamoxifen for the treatment of breast cancer. Hormone Therapy in Breast and Prostate Cancer I 2002, 1-13. Haman Press, Totowa N.J., USA. V.C. Jordan, B.R.A. Furr (Eds.).
-
(2002)
Hormone Therapy in Breast and Prostate Cancer I
, pp. 1-13
-
-
Jordan, V.C.1
-
14
-
-
79956139441
-
An introduction to the regulation of sex steroids for the treatment of cancer
-
Pub Haman Press, Totowa N.J., USA, V.C. Jordan, B.R.A. Furr (Eds.)
-
Jordan V.C., Furr B.J.A. An introduction to the regulation of sex steroids for the treatment of cancer. Hormone Therapy in Breast and Prostate Cancer I 2002, 185-194. Pub Haman Press, Totowa N.J., USA. V.C. Jordan, B.R.A. Furr (Eds.).
-
(2002)
Hormone Therapy in Breast and Prostate Cancer I
, pp. 185-194
-
-
Jordan, V.C.1
Furr, B.J.A.2
-
15
-
-
34548445351
-
Molecular response to aromatase inhibitor treatment in primary breast cancer
-
Mackay A., Urruticoechea A., Dixon J.M., Dexter T., Fenwick K., Ashworth A., Drury S., Larionov A., Young O., White S., Miller W.R., Evans D.B., Dowsett M. Molecular response to aromatase inhibitor treatment in primary breast cancer. Breast Cancer Res. 2007, 9:R37.
-
(2007)
Breast Cancer Res.
, vol.9
-
-
Mackay, A.1
Urruticoechea, A.2
Dixon, J.M.3
Dexter, T.4
Fenwick, K.5
Ashworth, A.6
Drury, S.7
Larionov, A.8
Young, O.9
White, S.10
Miller, W.R.11
Evans, D.B.12
Dowsett, M.13
-
16
-
-
78149481136
-
The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis
-
McCready J., Arendt L.M., Rudnick J.A., Kuperwasser C. The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis. Breast Cancer Res. 2010, 12:205.
-
(2010)
Breast Cancer Res.
, vol.12
, pp. 205
-
-
McCready, J.1
Arendt, L.M.2
Rudnick, J.A.3
Kuperwasser, C.4
-
17
-
-
77953027846
-
Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer
-
Mello-Grand M., Singh V., Ghimenti C., Scatolini M., Regolo L., Grosso E., Zambelli A., Da Prada G.A., Villani L., Fregoni V., Baiardi P., Marsoni S., Miller W.R., Costa A., Chiorino G. Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer. Breast Cancer Res. Treat. 2010, 121:399-411.
-
(2010)
Breast Cancer Res. Treat.
, vol.121
, pp. 399-411
-
-
Mello-Grand, M.1
Singh, V.2
Ghimenti, C.3
Scatolini, M.4
Regolo, L.5
Grosso, E.6
Zambelli, A.7
Da Prada, G.A.8
Villani, L.9
Fregoni, V.10
Baiardi, P.11
Marsoni, S.12
Miller, W.R.13
Costa, A.14
Chiorino, G.15
-
18
-
-
1542316334
-
Biological rationale for endocrine therapy in breast cancer
-
Miller W.R. Biological rationale for endocrine therapy in breast cancer. Best Pract. Res. Clin. Endocrinol. Metab. 2003, 18:1-32.
-
(2003)
Best Pract. Res. Clin. Endocrinol. Metab.
, vol.18
, pp. 1-32
-
-
Miller, W.R.1
-
19
-
-
77957587087
-
Background and development of aromatase inhibitors
-
Verlag Basel Boson, Berlin, B.J.A. Furr (Ed.)
-
Miller W.R. Background and development of aromatase inhibitors. Aromatase Inhibitors Birkhauser 2006, 1-21. Verlag Basel Boson, Berlin. B.J.A. Furr (Ed.).
-
(2006)
Aromatase Inhibitors Birkhauser
, pp. 1-21
-
-
Miller, W.R.1
-
20
-
-
33646820924
-
Aromatase inhibitors and breast cancer
-
Miller W.R. Aromatase inhibitors and breast cancer. Minerva Endocrinol. 2006, 31:27-46.
-
(2006)
Minerva Endocrinol.
, vol.31
, pp. 27-46
-
-
Miller, W.R.1
-
21
-
-
77950353241
-
Clinical, pathological, proliferative and molecular responses associated with neoadjuvant aromatase inhibitor treatment in breast cancer
-
Miller W.R. Clinical, pathological, proliferative and molecular responses associated with neoadjuvant aromatase inhibitor treatment in breast cancer. J. Steroid Biochem. Mol. Biol. 2010, 118:273-276.
-
(2010)
J. Steroid Biochem. Mol. Biol.
, vol.118
, pp. 273-276
-
-
Miller, W.R.1
-
22
-
-
0023519279
-
The importance of local synthesis of estrogen within the breast
-
Miller W.R., O'Neill J. The importance of local synthesis of estrogen within the breast. Steroids 1987, 50:537-548.
-
(1987)
Steroids
, vol.50
, pp. 537-548
-
-
Miller, W.R.1
O'Neill, J.2
-
23
-
-
0037152659
-
Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer
-
Miller W.R., Stuart M., Sahmoud T., Dixon J.M. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer. Br. J. Cancer 2002, 87:950-955.
-
(2002)
Br. J. Cancer
, vol.87
, pp. 950-955
-
-
Miller, W.R.1
Stuart, M.2
Sahmoud, T.3
Dixon, J.M.4
-
24
-
-
0345314101
-
Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen
-
Miller W.R., Dixon J.M., Macfarlane L., Cameron D., Anderson T.J. Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen. Eur. J. Cancer 2003, 39:462-468.
-
(2003)
Eur. J. Cancer
, vol.39
, pp. 462-468
-
-
Miller, W.R.1
Dixon, J.M.2
Macfarlane, L.3
Cameron, D.4
Anderson, T.J.5
-
25
-
-
33645735920
-
Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole
-
Miller W.R., White S., Dixon J.M., Murray J., Renshaw L., Anderson T.J. Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole. Br. J. Cancer 2006, 94:1051-1056.
-
(2006)
Br. J. Cancer
, vol.94
, pp. 1051-1056
-
-
Miller, W.R.1
White, S.2
Dixon, J.M.3
Murray, J.4
Renshaw, L.5
Anderson, T.J.6
-
26
-
-
34648858600
-
Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole
-
Miller W.R., Larionov A.A., Renshaw L., Anderson T.J., White S., Murray J., Murray E., Hampton G., Walker J.R., Ho S., Krause A., Evans D.B., Dixon J.M. Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole. Pharmacogenet. Genomics 2007, 17:813-826.
-
(2007)
Pharmacogenet. Genomics
, vol.17
, pp. 813-826
-
-
Miller, W.R.1
Larionov, A.A.2
Renshaw, L.3
Anderson, T.J.4
White, S.5
Murray, J.6
Murray, E.7
Hampton, G.8
Walker, J.R.9
Ho, S.10
Krause, A.11
Evans, D.B.12
Dixon, J.M.13
-
27
-
-
50649113295
-
Aromatase inhibitors: are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matterŽ
-
Miller W.R., Bartlett J., Brodie A.M., Brueggemeier R.W., di Salle E., Lonning P.E., Llombart A., Maass N., Maudelonde T., Sasano H., Goss P.E. Aromatase inhibitors: are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matterŽ. Oncologist 2008, 13:829-837.
-
(2008)
Oncologist
, vol.13
, pp. 829-837
-
-
Miller, W.R.1
Bartlett, J.2
Brodie, A.M.3
Brueggemeier, R.W.4
di Salle, E.5
Lonning, P.E.6
Llombart, A.7
Maass, N.8
Maudelonde, T.9
Sasano, H.10
Goss, P.E.11
-
28
-
-
38749100194
-
Predicting response and resistance to endocrine therapy: profiling patients on aromatase inhibitors
-
Miller W.R., Larionov A., Anderson T.J., Walker J.R., Krause A., Evans D.B., Dixon J.M. Predicting response and resistance to endocrine therapy: profiling patients on aromatase inhibitors. Cancer 2008, 112:689-694.
-
(2008)
Cancer
, vol.112
, pp. 689-694
-
-
Miller, W.R.1
Larionov, A.2
Anderson, T.J.3
Walker, J.R.4
Krause, A.5
Evans, D.B.6
Dixon, J.M.7
-
29
-
-
63049137792
-
Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole
-
Miller W.R., Larionov A., Renshaw L., Anderson T.J., Walker J.R., Krause A., Sing T., Evans D.B., Dixon J.M. Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole. J. Clin. Oncol. 2009, 27:1382-1387.
-
(2009)
J. Clin. Oncol.
, vol.27
, pp. 1382-1387
-
-
Miller, W.R.1
Larionov, A.2
Renshaw, L.3
Anderson, T.J.4
Walker, J.R.5
Krause, A.6
Sing, T.7
Evans, D.B.8
Dixon, J.M.9
-
30
-
-
84856227277
-
-
Sequential changes in gene expression profiles in breast cancers during treatment with the aromatase inhibitor, letrozole.
-
Miller, W.R., Larionov, A.A., Ivens, A., Anderson, T.J., Evans, D.B., Dixon, J.M., 2010a. Sequential changes in gene expression profiles in breast cancers during treatment with the aromatase inhibitor, letrozole. Pharmacogenomics J., doi:10.1038/tpj.2010.67.
-
(2010)
Pharmacogenomics J.
-
-
Miller, W.R.1
Larionov, A.A.2
Ivens, A.3
Anderson, T.J.4
Evans, D.B.5
Dixon, J.M.6
-
31
-
-
77956296913
-
Genes discriminating between breast cancers responsive or resistant to the aromatase inhibitor, letrozole
-
Miller W.R., Krause A., Larionov A., Evans D.B., Anderson T.J., Dixon J.M. Genes discriminating between breast cancers responsive or resistant to the aromatase inhibitor, letrozole. Eur. J. Clin. Med. Oncol. 2010, 2:17-22.
-
(2010)
Eur. J. Clin. Med. Oncol.
, vol.2
, pp. 17-22
-
-
Miller, W.R.1
Krause, A.2
Larionov, A.3
Evans, D.B.4
Anderson, T.J.5
Dixon, J.M.6
-
32
-
-
17844386351
-
Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes
-
Moggs J.G., Murphy T.C., Lim F.L., Moore D.J., Stuckey R., Antrobus K., Kimber I., Orphanides G. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes. J. Mol. Endocrinol. 2005, 34:535-551.
-
(2005)
J. Mol. Endocrinol.
, vol.34
, pp. 535-551
-
-
Moggs, J.G.1
Murphy, T.C.2
Lim, F.L.3
Moore, D.J.4
Stuckey, R.5
Antrobus, K.6
Kimber, I.7
Orphanides, G.8
-
33
-
-
0034724886
-
Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line
-
Molloy C.A., May F.E., Westley B.R. Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line. J. Biol. Chem. 2000, 275:12565-12571.
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 12565-12571
-
-
Molloy, C.A.1
May, F.E.2
Westley, B.R.3
-
34
-
-
0026075029
-
Concentrations of oestrone and 4-hydroxyandrostenedione in malignant and normal breast tissues
-
Reed M.J., Aherne G.W., Ghilchik M.W., Patel S., Chakraborty J. Concentrations of oestrone and 4-hydroxyandrostenedione in malignant and normal breast tissues. Int. J. Cancer 1991, 49:562-565.
-
(1991)
Int. J. Cancer
, vol.49
, pp. 562-565
-
-
Reed, M.J.1
Aherne, G.W.2
Ghilchik, M.W.3
Patel, S.4
Chakraborty, J.5
|